Vivo Cannabis Sees CEO, Chairman Announce Retirements

Vivo Cannabis (TSX: VIVO) this morning has announced the retirement of both its Chairman Paul Lucas, as well as its CEO Barry Fishman. Both retirements will be effective as of December 31, 2020, with the company to be lead by an interim CEO ahead of the company identifying a permanent replacement.

Independent director Richard Fitzgerald will be taking on both the Chairman role and that of the interim CEO role. Fitzgerald is currently the chair of the governance and nominating committee for the issuer, and is said to have “decades of experience in consumer insights, brand building and marketing.”

Commenting on his departure, Fishman commented that it was the “optimal time to transition to a new CEO to elevate the company to the next level.” Given the timing of the joint retirement, its unclear whether or not the retirement of both the CEO and Chairman was “optional” or not.

Vivo Cannabis last traded at $0.12 on the TSX.


Information for this briefing was found via Sedar and Vivo Cannabis. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

2 Responses

Video Articles

The Hidden Environmental Cost of Fertilizer | Robin Dow

Could Silver Stay This High? | Joaquín Marias – Argenta Silver

Can Historic Silver Data Turn Into a New Mine? | Rob Macdonald – Equity Metals

Recommended

First Majestic Drills 3.43 g/t Gold Over 24.4 Metres At Jerritt Canyon

Goliath Resources Secures 100% Ownership of Golddigger Property in BC’s Golden Triangle

Related News

Vivo Cannabis Sees Majority Of Board Resign Due To “Strategic Differences”

Vivo Cannabis (TSX: VIVO) appears to be going through in-fighting in terms of the direction...

Monday, July 5, 2021, 08:25:30 AM

Vivo Cannabis Reduces Outstanding Debentures From $27.1 Million To $6.6 Million

Vivo Cannabis (TSX: VIVO) has significant reduced its outstanding debt obligations through amendments to certain...

Wednesday, September 16, 2020, 09:08:13 AM

MediPharm Labs, Vivo Cannabis Slump After Announcing All-Stock Deal

MediPharm Labs (TSX: LABS) announced on Thursday an all-equity deal to acquire VIVO Cannabis (TSX:...

Sunday, December 25, 2022, 01:35:00 PM

Vivo Cannabis Cancels $5.1 Million Financing Over Unusual Trading Activity

Vivo Cannabis (TSX: VIVO) this morning announced that it has cancelled a proposed $5.1 million...

Friday, October 16, 2020, 08:18:03 AM

VIVO Cannabis Enters Into Research Partnership with CB2 Insights

This morning, CB2 Insights (CSE: CBII) announced it has entered into an agreement with that...

Tuesday, October 29, 2019, 04:52:32 PM